Partnership Will Make Kizik’s Hands-Free Easy-On-And-Off Shoes More Available to Those Living With Parkinson’s Disease
MIAMI & NEW YORK (September 1, 2020) — Kizik, a Utah-based footwear company that revolutionized the easy-on-and-off shoe industry, announced it has made a donation to the Parkinson’s Foundation. Kizik will collaborate with the Parkinson’s Foundation to make Kizik® shoes more available to those living with Parkinson’s disease, fulfilling the Foundation’s mission to make life better for -people with Parkinson’s.
“At Kizik, our mission is to make putting on and taking off shoes easier for everyone – and in particular for individuals who live with conditions that make tying shoes difficult or impossible. We are honored to partner with the Parkinson’s Foundation, and we believe this collaboration will enable us to make life easier for millions of people living with Parkinson’s disease,” said Monte Deere, Chief Executive Officer of Kizik.
For people with Parkinson’s disease, daily tasks can become more difficult to perform. Getting dressed may be a slower and more laborious process. Kizik’s F.A.S.T.® (Foot Activated Shoe Technology), functionality and design can help people with Parkinson’s alleviate some of these challenges.
Based in Vineyard, Utah, KIZIK is a technology inspired footwear brand that invents fashionable handsfree footwear with modern design solutions to improve convenience in everyday life through its patented F.A.S.T.® solutions. For more information, visit KIZIK.com and follow @wearKIZIK.
About the Parkinson’s Foundation
The Parkinson’s Foundation makes life better for people with Parkinson’s disease by improving care and advancing research toward a cure. In everything we do, we build on the energy, experience and passion of our global Parkinson’s community. Since 1957, the Parkinson’s Foundation has invested more than $400 million in Parkinson’s research and clinical care. Connect with us on Parkinson.org, Facebook, Twitter, Instagram or call (800) 4PD-INFO (473-4636).
About Parkinson’s Disease
Affecting an estimated one million Americans and 10 million worldwide, Parkinson’s disease is the second-most common neurodegenerative disease after Alzheimer’s and is the 14th-leading cause of death in the U.S. It is associated with a progressive loss of motor control (e.g., shaking or tremor at rest and lack of facial expression), as well as non-motor symptoms (e.g., depression and anxiety). There is no cure for Parkinson’s and 60,000 new cases are diagnosed each year in the U.S. alone.